These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18464119)

  • 1. Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes.
    Caudill JS; Porcher JC; Steensma DP
    Leuk Lymphoma; 2008 May; 49(5):989-93. PubMed ID: 18464119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C.
    Skrdlant L; Stark JM; Lin RJ
    BMC Mol Biol; 2016 Aug; 17(1):18. PubMed ID: 27552991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes.
    Kataoka N; Matsumoto E; Masaki S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of Aberrant Splicing in Pathogenesis of Myelodysplastic Syndromes-Review].
    Li L; Xiao ZJ; Sun XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):617-621. PubMed ID: 28446323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes.
    Yip BH; Dolatshad H; Roy S; Pellagatti A; Boultwood J
    Curr Pharm Des; 2016; 22(16):2333-44. PubMed ID: 26916023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
    Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
    Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering transcription and splicing networks in myelodysplastic syndromes.
    Wang H; Wen J; Chang CC; Zhou X
    PLoS One; 2013; 8(11):e79118. PubMed ID: 24244432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of CDC25 phosphatases splice variants in human breast cancer cells.
    Albert H; Santos S; Battaglia E; Brito M; Monteiro C; Bagrel D
    Clin Chem Lab Med; 2011 Oct; 49(10):1707-14. PubMed ID: 21675940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Point mutations of genes encoding proteins involvedin RNA splicing in patients with myelodysplastic syndromes].
    Barańska M; Czerwińska-Rybak J; Gil L; Komarnicki M
    Pol Merkur Lekarski; 2015 Jan; 38(223):5-10. PubMed ID: 25763580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
    Scott LM; Rebel VI
    J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
    Boultwood J; Dolatshad H; Varanasi SS; Yip BH; Pellagatti A
    Adv Biol Regul; 2014 Jan; 54():153-61. PubMed ID: 24080589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C.
    Wegener S; Hampe W; Herrmann D; Schaller HC
    Eur J Cell Biol; 2000 Nov; 79(11):810-5. PubMed ID: 11139144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer.
    Ozen M; Ittmann M
    Clin Cancer Res; 2005 Jul; 11(13):4701-6. PubMed ID: 16000564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines.
    Albert H; Battaglia E; Monteiro C; Bagrel D
    Mol Oncol; 2012 Oct; 6(5):542-52. PubMed ID: 22871320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C.
    Xu N; Ren Y; Bao Y; Shen X; Kang J; Wang N; Wang Z; Han X; Li Z; Zuo J; Wei GH; Wang Z; Zong WX; Liu W; Xie G; Wang Y
    Cell Rep; 2023 Sep; 42(9):113041. PubMed ID: 37682709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
    Yip BH; Steeples V; Repapi E; Armstrong RN; Llorian M; Roy S; Shaw J; Dolatshad H; Taylor S; Verma A; Bartenstein M; Vyas P; Cross NC; Malcovati L; Cazzola M; Hellström-Lindberg E; Ogawa S; Smith CW; Pellagatti A; Boultwood J
    J Clin Invest; 2017 Jun; 127(6):2206-2221. PubMed ID: 28436936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing Factor Mutations in Cancer.
    Bejar R
    Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
    Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Verma A; Norbury CJ; Hellström-Lindberg E; Wainscoat JS; Boultwood J
    Leukemia; 2010 Apr; 24(4):756-64. PubMed ID: 20220779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular pathogenesis of the myelodysplastic syndromes.
    Pellagatti A; Boultwood J
    Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.